Zun-yi Zhang - Publications

Folate receptor-positive circulating tumor cells might function as potential biomarkers for hepatocellular carcinoma.

Journal: World journal of gastrointestinal oncology

Published: August 26, 2025

Revisiting the role of local treatments in the era of targeted therapy and immunotherapy for hepatocellular carcinoma.

Journal: World journal of surgical oncology

Published: April 06, 2025

Machine learning prediction of perineural invasion in intrahepatic cholangiocarcinoma.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 26, 2025

Conversion treatment for advanced intrahepatic cholangiocarcinoma: Opportunities and challenges.

Journal: World journal of gastroenterology

Published: January 05, 2025

Adjuvant PD-1 inhibitors improve recurrence and survival outcomes in high-risk hepatocellular carcinoma patients after curative hepatectomy.

Journal: European journal of medical research

Published: September 18, 2024

Autologous Tumor-Infiltrating Lymphocyte Infusion plus Anti-Programmed Cell Death Protein 1 Therapy to Cure Advanced Hepatocellular Carcinoma following Palliative Hepatectomy.

Journal: Liver cancer

Published: September 06, 2024

Scientific Hepatectomy for Hepatocellular Carcinoma.

Journal: Current medical science

Published: February 23, 2023

Splenectomy may facilitate systemic therapy for advanced hepatocellular carcinoma with hypersplenism.

Journal: Hepatobiliary surgery and nutrition

Published: November 09, 2022

Case Report: Solitary metastasis to the appendix after curative treatment of HCC.

Journal: Frontiers in surgery

Published: October 27, 2022

Conversion therapy for advanced intrahepatic cholangiocarcinoma with lenvatinib and pembrolizumab combined with gemcitabine plus cisplatin: A case report and literature review.

Journal: Frontiers in immunology

Published: October 25, 2022

A combined pre- and intra-operative nomogram in evaluation of degrees of liver cirrhosis predicts post-hepatectomy liver failure: a multicenter prospective study.

Journal: Hepatobiliary surgery and nutrition

Published: September 05, 2022

USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling.

Journal: Cell death & disease

Published: May 07, 2022